Patients With Advanced Solid Tumors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patients with advanced solid tumors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patients With Advanced Solid Tumors Today - Breaking & Trending Today

Dr Kummar on the Evaluation of Rezatapopt in Advanced Solid Tumors

Shivaani Kummar, MD, FACP, discusses the evaluation of rezatapopt in patients with advanced solid tumors. ....

United States , Shivaani Kummar , Division Of Hematology Medical Oncology , Oregon Health Science University School Of Medicine , International Conference On Molecular , Knight Cancer Institute , Cancer Research , Division Head , Lester Dearmond Endowed Chair , Medical Oncology , Oregon Health , Science University School , Experimental Therapeutics , Molecular Targets , Cancer Therapeutics , Patients With Advanced Solid Tumors ,

GZ17-6.02 Effective in Killing Multiple Myeloma Cells, Other Benefits When Combined With Bortezomib

The combination of GZ17-6.02 and bortezomib reduced of HDAC, and as a result ATG13 phosphorylation was enhanced, BAK levels increased, and BCL-XL levels were reduced. ....

Vitalii Vodolazskyi , Genzada Pharmaceuticals United States Inc , Impact Journals , Study Evaluating , Patients With Advanced Solid Tumors , Combination With Capecitabine , Genzada Pharmaceuticals United States ,

Repotrectinib Sustains ORR, Safety in Locally Advanced or Metastatic ROS1+ NSCLC

Treatment with repotrectinib continued to produce high and durable responses with a manageable safety profile in patients with ROS1-positive locally advanced or metastatic non–small cell lung cancer who were naïve to a TKI or previously treated with 1 TKI and no chemotherapy. ....

South Korea , Soult Ukpyolsi , Joseph Fiore , Byoung Chul Cho , Cancer Laboratory , Drug Administration , Yonsei Cancer Center , Bristol Myers Squibb , Yonsei University College Of Medicine , Lung Cancer , Chul Cho , Yonsei University College , Prescription Drug User Fee , Point Therapeutics , Patients With Advanced Solid Tumors , Trident 1 ,

BAT8006 Elicits Disease Control, Safety in Advanced Ovarian Cancer and Other Solid Tumors

Treatment with the folate receptor–α antibody-drug conjugate BAT8006 led to responses with a manageable safety profile in patients with advanced solid tumors, including ovarian cancer, breast cancer, and cervical cancer. ....

Patients With Advanced Solid Tumors , Ovarian Cancer , Breast Cancer , Cervical Cancer ,

A2B530 Harnesses Unique Mechanism of Action to Integrate CAR T in Solid Tumors

Looking to replicate the impressive findings with CAR T-cell therapies observed in patients with hematologic malignancies, investigators have initiated the BASECAMP-1 trial with the hope of identifying patients with advanced solid tumors who will be suitable candidates for treatment in the EVEREST trial. ....

United States , New York , Kedar Kirtane , Dianem Simeone , Department Of Head , Perlmutter Cancer Center , Society For Immunotherapy Of Cancer , Pancreatic Cancer Center , Endocrine Oncology At Moffitt Cancer Center , Neck Endocrine Oncology , Moffitt Cancer Center , Annual Meeting , Tmodt Cell , Accessed April , Cart Cell Therapies Observed In Patients With Hematologic Malignancies , Basecamp 1 Trial , Patients With Advanced Solid Tumors , Everest Trial ,